Cargando…

Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca

Sjögren syndrome (SS) is an autoimmune condition that targets the salivary and lacrimal glands, with cardinal clinical signs of dry eye (keratoconjunctivitis sicca, KCS) and dry mouth. The conjunctiva of SS patients is often infiltrated by immune cells that participate in the induction and maintenan...

Descripción completa

Detalles Bibliográficos
Autores principales: de Paiva, Cintia S., Trujillo-Vargas, Claudia M., Schaefer, Laura, Yu, Zhiyuan, Britton, Robert A., Pflugfelder, Stephen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326832/
https://www.ncbi.nlm.nih.gov/pubmed/34349764
http://dx.doi.org/10.3389/fimmu.2021.702755
_version_ 1783731933272866816
author de Paiva, Cintia S.
Trujillo-Vargas, Claudia M.
Schaefer, Laura
Yu, Zhiyuan
Britton, Robert A.
Pflugfelder, Stephen C.
author_facet de Paiva, Cintia S.
Trujillo-Vargas, Claudia M.
Schaefer, Laura
Yu, Zhiyuan
Britton, Robert A.
Pflugfelder, Stephen C.
author_sort de Paiva, Cintia S.
collection PubMed
description Sjögren syndrome (SS) is an autoimmune condition that targets the salivary and lacrimal glands, with cardinal clinical signs of dry eye (keratoconjunctivitis sicca, KCS) and dry mouth. The conjunctiva of SS patients is often infiltrated by immune cells that participate in the induction and maintenance of local inflammation. The purpose of this study was to investigate immune-related molecular pathways activated in the conjunctiva of SS patients. Female SS patients (n=7) and controls (n=19) completed a series of oral, ocular surface exams. Symptom severity scores were evaluated using validated questionnaires (OSDI and SANDE). All patients fulfilled the ACR/EULAR criteria for SS and the criteria for KCS. Fluorescein and lissamine green dye staining evaluated tear-break-up time (TBUT), corneal and conjunctival disease, respectively. Impression cytology of the temporal bulbar conjunctiva was performed to collect cells lysed and subjected to gene expression analysis using the NanoString Immunology Panel. 53/594 differentially expressed genes (DEGs) were observed between SS and healthy controls; 49 DEGs were upregulated, and 4 were downregulated (TRAF5, TGFBI, KLRAP1, and CMKLRI). The top 10 DEGs in descending order were BST2, IFITM1, LAMP3, CXCL1, IL19, CFB, LY96, MX1, IL4R, CDKN1A. Twenty pathways had a global significance score greater or equal to 2. Spearman correlations showed that 29/49 upregulated DEGs correlated with either TBUT (inverse) or OSDI or conjunctival staining score (positive correlations). Venn diagrams identified that 26/29 DEGs correlated with TBUT, 5/26 DEGs correlated with OSDI, and 16/26 correlated with conjunctival staining scores. Five upregulated DEGs (CFB, CFI, IL1R1, IL2RG, IL4R) were uniquely negatively correlated with TBUT. These data indicate that the conjunctiva of SS patients exhibits a phenotype of immune activation, although some genes could be inhibitory. Some of the DEGs and pathways overlap with previous DEGs in salivary gland biopsies, but new DEGs were identified, and some of these correlated with symptoms and signs of dry eye. Our results indicate that gene analysis of conjunctiva imprints is a powerful tool to understand the pathogenesis of SS and develop new therapeutic targets.
format Online
Article
Text
id pubmed-8326832
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83268322021-08-03 Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca de Paiva, Cintia S. Trujillo-Vargas, Claudia M. Schaefer, Laura Yu, Zhiyuan Britton, Robert A. Pflugfelder, Stephen C. Front Immunol Immunology Sjögren syndrome (SS) is an autoimmune condition that targets the salivary and lacrimal glands, with cardinal clinical signs of dry eye (keratoconjunctivitis sicca, KCS) and dry mouth. The conjunctiva of SS patients is often infiltrated by immune cells that participate in the induction and maintenance of local inflammation. The purpose of this study was to investigate immune-related molecular pathways activated in the conjunctiva of SS patients. Female SS patients (n=7) and controls (n=19) completed a series of oral, ocular surface exams. Symptom severity scores were evaluated using validated questionnaires (OSDI and SANDE). All patients fulfilled the ACR/EULAR criteria for SS and the criteria for KCS. Fluorescein and lissamine green dye staining evaluated tear-break-up time (TBUT), corneal and conjunctival disease, respectively. Impression cytology of the temporal bulbar conjunctiva was performed to collect cells lysed and subjected to gene expression analysis using the NanoString Immunology Panel. 53/594 differentially expressed genes (DEGs) were observed between SS and healthy controls; 49 DEGs were upregulated, and 4 were downregulated (TRAF5, TGFBI, KLRAP1, and CMKLRI). The top 10 DEGs in descending order were BST2, IFITM1, LAMP3, CXCL1, IL19, CFB, LY96, MX1, IL4R, CDKN1A. Twenty pathways had a global significance score greater or equal to 2. Spearman correlations showed that 29/49 upregulated DEGs correlated with either TBUT (inverse) or OSDI or conjunctival staining score (positive correlations). Venn diagrams identified that 26/29 DEGs correlated with TBUT, 5/26 DEGs correlated with OSDI, and 16/26 correlated with conjunctival staining scores. Five upregulated DEGs (CFB, CFI, IL1R1, IL2RG, IL4R) were uniquely negatively correlated with TBUT. These data indicate that the conjunctiva of SS patients exhibits a phenotype of immune activation, although some genes could be inhibitory. Some of the DEGs and pathways overlap with previous DEGs in salivary gland biopsies, but new DEGs were identified, and some of these correlated with symptoms and signs of dry eye. Our results indicate that gene analysis of conjunctiva imprints is a powerful tool to understand the pathogenesis of SS and develop new therapeutic targets. Frontiers Media S.A. 2021-07-19 /pmc/articles/PMC8326832/ /pubmed/34349764 http://dx.doi.org/10.3389/fimmu.2021.702755 Text en Copyright © 2021 de Paiva, Trujillo-Vargas, Schaefer, Yu, Britton and Pflugfelder https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
de Paiva, Cintia S.
Trujillo-Vargas, Claudia M.
Schaefer, Laura
Yu, Zhiyuan
Britton, Robert A.
Pflugfelder, Stephen C.
Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca
title Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca
title_full Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca
title_fullStr Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca
title_full_unstemmed Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca
title_short Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca
title_sort differentially expressed gene pathways in the conjunctiva of sjögren syndrome keratoconjunctivitis sicca
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326832/
https://www.ncbi.nlm.nih.gov/pubmed/34349764
http://dx.doi.org/10.3389/fimmu.2021.702755
work_keys_str_mv AT depaivacintias differentiallyexpressedgenepathwaysintheconjunctivaofsjogrensyndromekeratoconjunctivitissicca
AT trujillovargasclaudiam differentiallyexpressedgenepathwaysintheconjunctivaofsjogrensyndromekeratoconjunctivitissicca
AT schaeferlaura differentiallyexpressedgenepathwaysintheconjunctivaofsjogrensyndromekeratoconjunctivitissicca
AT yuzhiyuan differentiallyexpressedgenepathwaysintheconjunctivaofsjogrensyndromekeratoconjunctivitissicca
AT brittonroberta differentiallyexpressedgenepathwaysintheconjunctivaofsjogrensyndromekeratoconjunctivitissicca
AT pflugfelderstephenc differentiallyexpressedgenepathwaysintheconjunctivaofsjogrensyndromekeratoconjunctivitissicca